.
. The last several years have witnessed a resurgence of interest in the identification of antigenic markers which distinguish tumour cells from their normal counterparts, foetal cells from those of adults and one differentiated cell from another. This renewed interest is due to the introduction of the hybridoma technique (Kohler & Milstein, 1975) , which has made it possible to produce monoclonal antibodies of desired specificities and to identify with precision the antigens that they recognize. It has been hoped that such 'tailor-made' monoclonal antibodies would single out antigenic markers which would be useful for the diagnosis of cancer, the immunotherapy of tumours and the typing of leukaemic cells and not least for detecting important components which change during successive stages of development and differentiation.
Abbreviation used: IgM, immunoglobulin M.
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In this report, I shall briefly review our studies which have shown that a number of such cellular markers recognized by monoclononal antibodies are carbohydrate structures. The antigenic markers in question are as diverse as (a) developmentally regulated antigens of human erythrocytes (Marsh, 1961) , (b) an antigenic marker of gastric adenocarcinoma in persons who are secretors of the blood group antigens (Picard et al., 1978; Feizi, 1979; Kapadia et al., 1981a) , (c) a marker of human colon adenocarcinoma (Brown et al., 1983) , (d) an antigenic marker of human foetal endoderm (Williams et al., 1982) , (e) distinctive markers of human granulocytes amongst cells of the peripheral blood (Rumpold et al., 1982; Brown et al., 1983) , (f) differentiation antigens of human breast epithelium (Foster et at., 1982) , (g) stage-specific embryonic antigen of mouse (Solter & Knowles, 1978) and (h) a marker of the primary endoderm of the mouse (Kapadia et al., 19816) . All these antigenic markers are carbohydrate structures carried on various glycoproteins and glycolipids of the cell surface (Feizi, 1981a (Feizi, , 1982a  Feizi, 1981b; Hakomori, 19816; Kapadia et al., 1981a; Feizi er al., 1982; (e) Feizi 19826; (f) Picardetal., 1978; Gooi etal., 1983b; (h) Feizi, 1983a; (i) Gooi et al., 1983a; Gooi et al., 1981 ; (k) Hounsell et al., 1981 ;  (1) Brown et al., 1983; Gooi et al., 1983c . The three carbohydrate domains on blood group-related oligosaccharides The blood group-related carbohydrate chains consist of three domains ( Fig. 1) : 'core', 'backbone', and 'peripheral' (reviewed by . Monosaccharides in the core region vary according to whether the oligosaccharides are joined by N-or 0-glycosidic linkage to protein (Kornfeld & Kornfeld, 1980; or to lipid (Hakomori, 1981~) . The antigens I shall discuss in this report are found associated with the backbones and the peripheral regions. The backbone regions consist of alternating galactose and N-acetylglucosamine residues joined by two types of linkage with differing antigenicities, known as Type 1 and Type 2 chains (Watkins, 1980) as follows:
Antigens
Type 1 Galpl-4GlcNAc
Type 2
In linear sequence the repeating disaccharide units are joined to one another by 1-3 linkage ( and may be longer or shorter than shown in Fig. 1 and they may be linear or branched in different cell types; their antigenicity varies accordingly. The backbone sequences may be further glycosylated with monosaccharides such as fucose, galactose or N-acetylgalactosamine to give rise to peripheral regions with differing antigenicities. Among these the best known are the major blood group antigens, A, B, H, Lea and Leb (Watkins, 1980) . The peripheral glycosylations often mask the antigenicities of the underlying backbone structures (Feizi, 1981a, b) . It is of considerable interest that there occur both natural and hybridoma-derived antibodies against this family of saccharide structures. Certain of these structures behave as tumour-associated antigens in some individuals but not in others . Furthermore, certain of these antigens are normal cellular components of some tissues but Table 1 occur as part of the backbone regions; monosaccharides in the peripheral regions may consist of fucose, galactose, N-acetylgalactosamine and sialic acid residues.
~ they behave as tumour-associated antigens in others . The unexpected aspect of all these findings (and this is being supported by observations from other groups) is that no unique structures have been revealed thus far. Tumour-associated and differentiation antigens associated with Type 2 backbone sequences In the sera of patients with the autoimmune haemolytic disorder known as cold agglutinin disease, there occur high titre monoclonal autoantibodies known as anti-I and anti-i cold agglutinins. It so happens that the I and i antigens recognized by these natural monoclonal antibodies are developmentally regulated carbohydrate structures (Feizi, 19816; Hakomori, 1981b) . The i antigen which is a linear oligosaccharide consists of repeating Type 2 sequences and is a prominent antigen of human foetal erythrocytes. In contrast it is the branched structure, I antigen, which predominates in the erythrocytes of adults ( Table 1) .
The I and i sequences serve as backbone structures for the H, A and B antigens (Fig. 2) (Feizi, 1981b; Hakomori, 19816) which occur not only on erythrocytes but also in various tissues of the body where their expression is developmentally regulated (Szulman, 1980) . Of special interest is the mode of expression of the antigens A, B and H and I in the gastric mucosa and the mucosal glycoproteins (gastric mucins) (reviewed by Feizi 198%; : in individuals who are secretors of the major blood group antigens (approx. 75% of the population), the gastric mucosa and gastric mucins strongly express the H, A or B antigens found on their erthroyctes. In contrast, in nonsecretors whose epithelial cells lack blood group Hconferring fucosyltransferase (Watkins, 198 I) , these antigens are lacking in the superficial gastric mucosa and the mucins they secrete. Instead, the I antigen is strongly expressed (Picard et al., 1978; ; in particular, the I antigenic determinant consisting of the branch point sequence :
recognized by anti-I Ma (Table 1, Fig. 2 ) is strongly expressed. On the other hand when secretors develop gastric cancer, the I(Ma) determinant is strongly expressed in their turnouts (Picard etal., 1978; ; this may be due to incomplete biosynthesis of the H, A or B determinants. Thus the I(Ma) determinant can be regarded as a 'distinctive' marker of the gastric mucosa of non-secretors but a tumour-associated antigen in the gastric cancer tissues of secretors (Table 1 ) . We are currently measuring the level of the I(Ma) antigen in the gastric juice of secretors in order to evaluate its potential as a diagnostic marker of gastric cancer.
The 1-4, 1 -6 linked branch can behave as a differentiation antigen in breast epithelial cells (Gooi et al., 1983a) , as shown by two hybridoma antibodies M 39 and M 18. These were raised by Foster et al. (1982) against human milk fat globules. These two hybridoma antibodies resemble anti-I(Ma) in their specificity for the branch point sequence ( Table 1 ) and their agglutination reactions with erythrocytes of adults (Gooi et al., 1983a) . However, there are differences in the fine specificities of these three antibodies (Gooi et al., 19836 ; Uemuraet al., 1983) such that they react with only partially overlapping sub-populations of breast epithelial cells.
In the mouse, the I and i antigens can be regarded as stage-specific antigens (Kapadia et al., 1981a; Feizi et al.,  1982) for the I but not the i antigen is expressed on the earliest mouse embryo, and the i antigen appears precisely at the onset of differentiation when the primary endoderm is formed (Table 1) . Thus the antigenic change from i to I during development, as seen with human erythrocytes, is not a general phenomenon and the reverse order may occur.
Fucosylated Type 2 chains may behave as dijjferentiation and tumour-associated antigens
The Type 2 chain when al-3 fucosylated as in (ffucosyl-N-acetyllactosamine, Table 1 ) behaves as a differentiation antigen in two systems (Table 1, Fig. 2 ). In the mouse this determinant Hounsell et al., 1981) is the eight-cell stage-specific embryonic antigen, known as SSEA-1, recognized by a monoclonal antibody raised by Solter & Knowles (1978) against the F9 teratocarcinoma cell line of the mouse. However, in man the same trisaccharide structure behaves (Feizi, 1983a; Gooi et al., 1983a) as a distinctive marker of granulocytes amongst cells of the peripheral blood, as recognized by two monoclonal antibodies, VEP8 and VEP9, raised by Rumpold et al. (1982) . It appears that approx. 50% of monoclonal antibodies against human myeloid cells recognize this determinant (H. C. Gooi, W. Knapp & T. Feizi, unpublished work); these include the monoclonal antibody VIM-D5 and several other monoclonal antibodies, VIM-4, VIM-7, VIM-9 VIM-C6 and VIM-6, raised by Knapp et al. (1983) . The remaining 50% of the myeloid cell-specific monoclonal antibodies including VIM-2 (Knapp et al., 1983) recognize saccharide structures which are distinct from 3-fucosyl-N-acetyllactosamine (K. Uemura, B. Macher, W. Knapp & T. Feizi, unpublished work) . A number of other laboratories have also reported monoclonal antibodies against myeloid cells which have specificity for 3-fucosyl-N-acetyllactosamine, as discussed by Magnani (1984) . Mice immunized with a number of human tumours have also produced antibodies with specificity for this structure (Hansson et al., 1983) . It is of interest that this antigen is not expressed as a granulocyte antigen in the mouse (S. Thorpe & T. Feizi, unpublished work). Thus, apart from individual and tissue differences in the expression of carbohydrate differentiation antigens , there are marked species differences.
At later stages of development the Ii and SSEA-1 antigens can no longer be detected in the majority of the tissues of the mouse (Kapadia et al., 1981a; Feizi et al., 1982) . In certain epithelial tissues the blood group H antigen is strongly expressed (Kapadia, 198 la) . Since the fucose residues associated with blood group H antigen mask the antigenicity of the I, i and SSEA-1 structures (Feizi et al., Fig. 2 ) express a tumour-associated antigen of human colonic epithelium as recognized by the hybridoma antibody C14 (Brown et al., 1983) . This antigen is, in addition, expressed as an intracellular antigen of human granulocytes (Brown et al., 1983 ; A. Brown, S. Thorpe & T. Feizi, unpublished work).
The interrelationships of these several antigens including the Type 2 based blood group H, A and B antigens are illustrated in Fig. 2. The Type I backbone structure as a marker of undifferentiated teratocarcinomas and foetal endodermal tissues of man Undifferentiated teratocarcinomas and endodermal tissues of the human foetus express an antigen recognized by a hybridoma antibody FC 10.2 which was produced by Williams et al. (1982) , following immunization of mice with formalin-fixed human embryonal caracinoma line LICR LON HT 39/7. We have shown (Gooi et al., 1983c) that the antigenic determinant recognized by this antibody involves the Type I-based sequence shown in Table 1 . This antibody shows little reaction with endodermal tissues of the adult, although the Type 1 sequence is well known to occur on glycoproteins and glycolipids (Karlsson & Larson, 1981) of the gastrointestinal tract. This is because the Type 1 sequence becomes a 1 4 fucosylated and converted to the Lea antigen or al-2 fucosylated and converted to the blood group H antigen or alternatively it may be difucosylated and converted into the Leb antigen as shown in Fig. 3 (Watkins, 1980) . These various glycosylations result in the masking of the FC 10.2 determinant. Presumably in the human foetus and in the undifferentiated teratocarcinoma cells a high proportion of the backbones are unsubstituted. The carbohydrate specificity of FC 10.2 antibody resembles that of a human Waldenstr~m macroglobulin, IgMWoo (Kabat et al., 1982) .
For completeness, it should be pointed out that the colon tumour-associated antigen recognized by the monoclonal antibody 19-9 produced in the laboratory of Koprowski has been shown by to involve the a2-3 sialylated form of the Lea antigen shown below:
NeuAca2-3Gal~l-3GlcNAc
Fuca Like the other tumour-associated antigens the 19-9 determinant is not confined to colonic adenocarcinomas but it has been reported to occur as a normal component of the pancreas (Hansson et al., 1983) .
Glycoprotein and glycolipid carriers of the tumour-associated and differentiation antigens
These blood group-related carbohydrate structures are well known to be carried on glycoproteins and glycolipids. We have recently compared their expression on glycoproteins and glycolipids of erythrocytes, granulocytes, the promyelocytic cell line HL 60, and mouse teratocarcinoma cells (Feizi, 19836; Childs et al., 1983 ; R. Childs, K. Uemura, B. Macher & T. Feizi, unpublished work) . Immunostaining of (a) total cell lysates after polyacrylamide-gel electrophoresis and transfer on to nitrocellulose ('Western' blotting) and (b) glycolipid extracts on thin-layer chromatography plates, has revealed that the proportion of glycoproteins and glycolipids carrying these antigens varies in different cell types. Precise quantifications are not possible by the techniques used; however, it can be stated that the I and i antigens are readily detected both on glycoproteins and glycolipid extracts of erythrocytes, and SSEA-1 is detectable on those of granulocytes and HL 60 cells. However, in teratocarcinoma cells of the mouse these antigens are detected predominantly on glycoproteins.
Conclusions
Thus we are dealing with an interrelated system of carbohydrate antigens which includes the major blood group antigens and whose expression changes during successive stages of embryogenesis, differentiation and oncogenesis. The changes in the expression of the blood group antigens in various organs of the human foetus at different stages of development have been reviewed by Szulman (1980) .
Our observations with monoclonal antibodies as well as studies from a number of other laboratories are reinforcing the concept that saccharides of the cell surface are important tumour-associated and differentiation antigens. However, none of the antigens thus far characterized has been uniquely specific for a given cell type or tumour. The changes we are observing seem to represent changes in the absolute amounts and the relative proportions of various carbohydrate structures, whose degree of expression in growing and differentiating cells is precisely programmed and genetically predictable. The changes in the carbohydrate structures may represent changes in (a) the availability of donor substrates, (b) the activities of glycosyltransferases or (c) the genes that code for the biosynthesis of these enzymes. The relationship of these changes to the neo-plastic process is unclear. The functions of the saccharide structures and their contributions to the properties of normal cells and to the abnormal behaviour of tumour cells are also not understood and will be the subject of future studies.
These glycosylation changes would be difficult to detect without the aid of monoclonal antibodies. Thus while the majority of these monoclonal antibodies may be inappropriate for the purpose for which they were raised, e.g. tumour diagnosis or immunotherapy (Feizi, 1983c) , they are of unquestioned value as precise biochemical and immunochemical tools. Through the use of well-characterized monoclonal antibodies it can be anticipated that important advances will be made in the biochemistry of the neoplastic and differentiation processes.
Throughout life there is a continuous formation of the different types of human blood cells in the bone marrow and lymphoid organs. The cells originate from a common stem cell and differentiate along separate pathways to the final mature cells. During the differentiation they acquire their characteristic morphologies according to which the major types of cells originally were named. Using various antisera and other markers it has, however, become apparent that the cells can be subtyped into several additional groups.
The most functionally interesting cell surface molecules comprising various antigens, receptors and 'markers' characteristic of the cellular subsets are proteins and glycolipids (Gahmberg & Anderson, 1982a,b) . Most of these proteins are glycoproteins (Gahmberg, 1976) with the carbohydrate exposed to the external milieu (Singer & Nicolson, 1972; Gahmberg & Hakomori, 1973; Steck & Dawson, 1974) . We believe that to be able to eventually understand how the haematopoietic cell surface functions, it is necessary to characterize it at the molecular level. We have approached this problem by first developing methods to radioactively label the carbohydrate portions of cell-surface glycoproteins and glycolipids. Using the enzyme galactose oxidase, cell surface-located galactosyllN-acetylgalactosaminyl residues of glycoproteins and glycolipids can specifically be oxidized (Gahmberg & Hakomori, 1973) . Alternatively cell-surface sialic acids are specifically oxidized using a low concentration of periodate at 0°C (Gahmberg & Anderson, 1977) . The generated aldehyde groups are subsequently reduced
